Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01586611
Title A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer
Acronym Panc001
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors AHS Cancer Control Alberta
Age Groups: adult
Covered Countries CAN

No variant requirements are available.